Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | GSK | ALNY | ||
| Company | Argenx Se ADR | Gsk Plc ADR | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 623.20 | 33.13 | 239.45 | ||
| High | 634.40 | 33.87 | 247.21 | ||
| Low | 619.60 | 33.04 | 235.93 | ||
| Last | 623.82 | 33.60 | 245.44 | ||
| Change | -2.21 | +0.17 | +6.57 | ||
| % Change | -0.35% | +0.51% | +2.75% | ||
| Volume | 313,100 | 6,813,000 | 1,663,500 | ||
| 20-Day Average Volume | 292,415 | 4,260,765 | 671,405 | ||
| Previous Close | 626.03 | 33.43 | 238.87 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 616.52 | 34.28 | 249.56 | ||
| 20-Day Raw Stochastic | 51.80% | 17.26% | 48.68% | ||
| 20-Day Relative Strength | 58.63% | 40.00% | 43.51% | ||
| Weighted Alpha | +74.52 | -16.88 | +7.65 | ||
| Today's Opinion | 100% Buy | 100% Sell | 8% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 96% Buy | 100% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.74% since 12/13/24 | -1.03% since 12/13/24 | unch since 12/13/24 | ||
| Low | 613.95 on 12/19/24 | 33.04 on 12/20/24 | 233.41 on 12/19/24 | ||
| High | 644.97 on 12/17/24 | 34.56 on 12/17/24 | 249.58 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +5.41% since 11/20/24 | +0.75% since 11/20/24 | -1.35% since 11/20/24 | ||
| Low | 582.07 on 11/21/24 | 33.04 on 12/20/24 | 233.41 on 12/19/24 | ||
| High | 644.97 on 12/17/24 | 36.28 on 12/09/24 | 258.12 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | +17.04% since 09/20/24 | -17.65% since 09/20/24 | -10.38% since 09/20/24 | ||
| Low | 512.01 on 09/24/24 | 32.83 on 11/15/24 | 229.85 on 11/18/24 | ||
| High | 644.97 on 12/17/24 | 41.80 on 10/09/24 | 304.39 on 10/17/24 | ||
| 6-Month | |||||
| %Chg | +60.83% since 06/20/24 | -17.57% since 06/20/24 | +55.93% since 06/20/24 | ||
| Low | 387.04 on 06/21/24 | 32.83 on 11/15/24 | 158.38 on 06/21/24 | ||
| High | 644.97 on 12/17/24 | 44.67 on 08/27/24 | 304.39 on 10/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 37,658,764 | 69,637,680 | 31,657,098 | ||
| Shares Outstanding, K | 60,368 | 2,072,550 | 128,981 | ||
| Annual Sales | 1,268,590,000 | 37,725,000,000 | 1,828,290,000 | ||
| Annual Net Income | -295,050,000 | 6,129,940,000 | -440,240,000 | ||
| Last Quarter Sales | 588,880,000 | 10,420,410,000 | 500,920,000 | ||
| Last Quarter Net Income | 91,410,000 | -75,430,000 | -111,570,000 | ||
| 60-Month Beta | 0.59 | 0.64 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.39 on 10/31/24 | 1.27 on 10/30/24 | -0.50 on 10/31/24 | ||
| Latest Earnings Date | 10/31/24 | 01/29/25 | 10/31/24 | ||
| Most Recent Dividend | N/A | 0.382 on 11/15/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/15/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 8.02 | 0.00 | ||